ESR1 and breast carcinoma: The successful imaging of ER/PR positive breast cancer cells using the construct with double ERE/PRE motivated us to further test it in experimental tumor models established with ER/PR negative (MDA-MB-231) and positive (MCF-7 and ZR-75-1) cancer cells.